Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

Fostering dialogue between neurologists, researchers, patient representatives, and policymakers is an important step towards ...

HTA as described by the HTA Regulation is the multidisciplinary scientific evidence-based process that allows to determine the relative effectiveness of new or existing health technologies. HTA is a ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

We're expecting renewed growth for Dutch manufacturing in 2025 following a very weak couple of years. Growth remains moderate ...

Stocks like Centum Electronics, NTPC Green Energy, Indian Bank, Urja Global, Bharat Electronics, NLC India, Ashoka Buildcon, ...

Anew Health plans a $20M IPO amid slowing revenue growth and market challenges. Discover insights on its expansion plans and ...

Britain's foreign secretary David Lammy, alongside his counterparts from France, Germany and Italy, have said they support an Arab-backed plan for the reconstruction of Gaza. The $53bn (£41bn ...

German Chancellor Olaf Scholz said Thursday that European countries must strengthen their defense capabilities in response to growing threats and shifts in US foreign policy. Speaking at a news ...